Cargando…
Antimicrobial activity of mul-1867, a novel antimicrobial compound, against multidrug-resistant Pseudomonas aeruginosa
BACKGROUND: There is an urgent need for new antimicrobial compounds to treat various lung infections caused by multidrug-resistant Pseudomonas aeruginosa (MDR-PA). METHODS: We studied the potency of Mul-1867 against MDR-PA isolates from patients with cystic fibrosis, chronic obstructive pulmonary di...
Autores principales: | Tetz, George, Vikina, Daria, Tetz, Victor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802586/ https://www.ncbi.nlm.nih.gov/pubmed/27001074 http://dx.doi.org/10.1186/s12941-016-0134-4 |
Ejemplares similares
-
In vitro antimicrobial activity of a novel compound, Mul-1867, against clinically important bacteria
por: Tetz, George, et al.
Publicado: (2015) -
In Vitro Activity of a Novel Antifungal Compound, MYC-053, against Clinically Significant Antifungal-Resistant Strains of Candida glabrata, Candida auris, Cryptococcus neoformans, and Pneumocystis spp.
por: Tetz, G., et al.
Publicado: (2019) -
Draft Genome Sequence of Streptococcus halitosis sp. nov., Isolated from the Dorsal Surface of the Tongue of a Patient with Halitosis
por: Tetz, George, et al.
Publicado: (2019) -
Overcoming Antibiotic Resistance with Novel Paradigms of Antibiotic Selection
por: Tetz, George, et al.
Publicado: (2022) -
Synergy Pattern of Short Cationic Antimicrobial Peptides Against Multidrug-Resistant Pseudomonas aeruginosa
por: Ruden, Serge, et al.
Publicado: (2019)